Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.

Oliveira CF, Botoni FA, Oliveira CR, Silva CB, Pereira HA, Serufo JC, Nobre V.

Crit Care Med. 2013 Oct;41(10):2336-43. doi: 10.1097/CCM.0b013e31828e969f.

PMID:
23921272
2.

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW.

Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2.

PMID:
26947523
3.

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J.

Am J Respir Crit Care Med. 2008 Mar 1;177(5):498-505. Epub 2007 Dec 20.

PMID:
18096708
4.

Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.

Prkno A, Wacker C, Brunkhorst FM, Schlattmann P.

Crit Care. 2013 Dec 11;17(6):R291. doi: 10.1186/cc13157. Review.

5.

[Comparison of procalcitonin, interleukin-6 and C-reactive protein in the differential diagnosis of patients with sepsis syndrome in intensive care units].

Průcha M, Herold I, Zazula R, Dubská L, Kavka B, Dostál M.

Vnitr Lek. 2003 Jul;49(7):541-7. Czech.

PMID:
12931436
6.

Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evaluation.

Venkatesh B, Kennedy P, Kruger PS, Looke D, Jones M, Hall J, Barruel GR.

Anaesth Intensive Care. 2009 Jan;37(1):20-6.

7.

Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting.

Deliberato RO, Marra AR, Sanches PR, Martino MD, Ferreira CE, Pasternak J, Paes AT, Pinto LM, dos Santos OF, Edmond MB.

Diagn Microbiol Infect Dis. 2013 Jul;76(3):266-71. doi: 10.1016/j.diagmicrobio.2013.03.027. Epub 2013 May 25.

PMID:
23711530
8.

[Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock].

Suberviola B, Castellanos-Ortega A, González-Castro A, García-Astudillo LA, Fernández-Miret B.

Med Intensiva. 2012 Apr;36(3):177-84. doi: 10.1016/j.medin.2011.09.008. Epub 2011 Nov 4. Spanish.

9.

Diagnostic and prognostic value of procalcitonin in patients with septic shock.

Clec'h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, Cohen Y.

Crit Care Med. 2004 May;32(5):1166-9.

PMID:
15190968
10.

Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.

Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A.

Crit Care Med. 2010 Nov;38(11):2229-41. doi: 10.1097/CCM.0b013e3181f17bf9. Review.

PMID:
20729729
11.

Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.

Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY.

Crit Care Med. 2006 Jul;34(7):1996-2003. Review.

PMID:
16715031
12.

[Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].

Pundiche M, Sârbu V, Unc OD, Grasa C, Martinescu A, Bădărău V, Durbală I, Sapte E, Pasăre R, Voineagu L, Iordache I, Vâncă A, Adam A.

Chirurgia (Bucur). 2012 Jan-Feb;107(1):71-8. Romanian.

PMID:
22480120
13.

Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation.

Heyland DK, Johnson AP, Reynolds SC, Muscedere J.

Crit Care Med. 2011 Jul;39(7):1792-9. doi: 10.1097/CCM.0b013e31821201a5. Review.

PMID:
21358400
14.

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.

Albrich WC, Harbarth S.

Intensive Care Med. 2015 Oct;41(10):1739-51. doi: 10.1007/s00134-015-3978-8. Epub 2015 Jul 21. Review.

PMID:
26194026
15.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Evid Based Child Health. 2013 Jul;8(4):1297-371. doi: 10.1002/ebch.1927. Review.

PMID:
23877944
16.

Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study.

Maseda E, Suarez-de-la-Rica A, Anillo V, Tamayo E, García-Bernedo CA, Ramasco F, Villagran MJ, Maggi G, Gimenez MJ, Aguilar L, Granizo JJ, Buño A, Gilsanz F.

J Crit Care. 2015 Jun;30(3):537-42. doi: 10.1016/j.jcrc.2014.12.014. Epub 2014 Dec 31.

PMID:
25600574
17.

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.

Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, Thornberg KJ, Løken J, Steensen M, Fox Z, Tousi H, Søe-Jensen P, Lauritsen AØ, Strange D, Petersen PL, Reiter N, Hestad S, Thormar K, Fjeldborg P, Larsen KM, Drenck NE, Ostergaard C, Kjær J, Grarup J, Lundgren JD; Procalcitonin And Survival Study (PASS) Group.

Crit Care Med. 2011 Sep;39(9):2048-58. doi: 10.1097/CCM.0b013e31821e8791.

PMID:
21572328
18.

Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.

Hohn A, Schroeder S, Gehrt A, Bernhardt K, Bein B, Wegscheider K, Hochreiter M.

BMC Infect Dis. 2013 Apr 1;13:158. doi: 10.1186/1471-2334-13-158.

19.

Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?

Iapichino G, Marzorati S, Umbrello M, Baccalini R, Barassi A, Cainarca M, Colombo Pavini F, Mantovani E, Mauri A, Moroni B, Noto A, Melzi D'Eril GV, Langer M.

Minerva Anestesiol. 2010 Oct;76(10):814-23. Epub 2010 Jul 1.

Supplemental Content

Support Center